Cargando…

Screening and clinical characteristics analysis of familial hypercholesterolemia in a tertiary public hospital

BACKGROUND AND AIMS: Familial hypercholesterolemia (FH) is becoming a global burden. However, it remains underdiagnosed and undertreated worldwide. This study aimed to observe the screening rate of FH patients and department distribution among hospitalized patients using different diagnostic criteri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Tianzhou, Fu, Qingan, Luo, Renfei, Wan, Yixin, Jiang, Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445126/ https://www.ncbi.nlm.nih.gov/pubmed/37621559 http://dx.doi.org/10.3389/fcvm.2023.1237261

Ejemplares similares

Recent Advances in Gene Therapy for Familial Hypercholesterolemia: An Update Review
por: Fu, Qingan, et al.
Publicado: (2022)

Applications of machine learning in familial hypercholesterolemia
por: Luo, Ren-Fei, et al.
Publicado: (2023)

Phenotypic vs. genetic cascade screening for familial hypercholesterolemia: A case report
por: Blokhina, Anastasia V., et al.
Publicado: (2022)

Hospitalized Children With Familial Hypercholesterolemia and COVID-19: A Case for Preventive Anticoagulation
por: Vuorio, Alpo, et al.
Publicado: (2021)

Percutaneous Coronary Intervention in Familial Hypercholesterolemia Is Understudied
por: Ungar, Leo, et al.
Publicado: (2018)

Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE)
por: Sudano, Isabella, et al.
Publicado: (2022)

Case report: Unusual coexistence between familial hypercholesterolemia and familial hypobetalipoproteinemia
por: Sasaki, Kei, et al.
Publicado: (2022)

Genetic Testing and Risk Scores: Impact on Familial Hypercholesterolemia
por: Sarraju, Ashish, et al.
Publicado: (2019)

Treatment patterns and use of healthcare resources of patients with atherosclerotic cardiovascular disease and hypercholesterolemia and patients with familial hypercholesterolemia in Spain: Protocol of the Reality study
por: Barrios, Vivencio, et al.
Publicado: (2022)

Correlation of cardiovascular risk predictors with overweight and obesity in patients with familial hypercholesterolemia
por: Wang, Yaodong, et al.
Publicado: (2022)

Prevalence of genetically defined familial hypercholesterolemia and the impact on acute myocardial infarction in Taiwanese population: A hospital-based study
por: Chen, Yen-Ju, et al.
Publicado: (2022)

Prevalence and prognosis of molecularly defined familial hypercholesterolemia in patients with acute coronary syndrome
por: Wang, Cheng, et al.
Publicado: (2022)

Maternal Hypercholesterolemia May Involve in Preterm Birth
por: Chen, Jingfei, et al.
Publicado: (2022)

Prevalence and Impact of Apolipoprotein E7 on LDL Cholesterol Among Patients With Familial Hypercholesterolemia
por: Tada, Hayato, et al.
Publicado: (2021)

Effect of causative genetic variants on atherosclerotic cardiovascular disease in heterozygous familial hypercholesterolemia patients
por: Matta, Anthony, et al.
Publicado: (2023)

Hypercholesterolemia and Lymphatic Defects: The Chicken or the Egg?
por: Miyazaki, Takuro, et al.
Publicado: (2021)

Association Between Familial Hypercholesterolemia and Risk of Cardiovascular Events and Death in Different Cohorts: A Meta-Analysis of 1.1 Million Subjects
por: Yu, Yani, et al.
Publicado: (2022)

Ostial Coronary Stenosis and Severe Aortic Stenosis in a Patient With Familial Hypercholesterolemia
por: Kaya, Hasan, et al.
Publicado: (2012)

The tertiary hospital laboratory; a novel avenue of opportunistic screening of familial hypercholesterolemia
por: Mirzaee, Sam, et al.
Publicado: (2019)

Developing a Hybrid Risk Assessment Tool for Familial Hypercholesterolemia: A Machine Learning Study of Chinese Arteriosclerotic Cardiovascular Disease Patients
por: Wang, Lei, et al.
Publicado: (2022)

Hypercholesterolemia and COVID-19: Statins for Lowering the Risk of Venous Thromboembolism
por: Vuorio, Alpo, et al.
Publicado: (2021)

The Prevalence of Familial Hypercholesterolemia (FH) in Chinese Patients With Acute Myocardial Infarction (AMI): Data From Chinese Acute Myocardial Infarction (CAMI) Registry
por: Shi, Hui-Wei, et al.
Publicado: (2020)

ODP137 Achilles Tendon Size and Characteristics for Diagnosis of Familial Hypercholesterolemia Among Thai Patients
por: Warachit Parksook, Wasita, et al.
Publicado: (2022)

Corrigendum: The Prevalence of Familial Hypercholesterolemia (FH) in Chinese Patients With Acute Myocardial Infarction (AMI): Data From Chinese Acute Myocardial Infarction (CAMI) Registry
por: Shi, Hui-Wei, et al.
Publicado: (2020)

Case Report: Difficulties in the Treatment of a 12-Year-Old Patient With Homozygous Familial Hypercholesterolemia, Compound Heterozygous Form − 5 Years Follow-Up
por: Vladimirova-Kitova, Lyudmila, et al.
Publicado: (2021)

Pericoronary radiomics texture features associated with hypercholesterolemia on a photon-counting-CT
por: Kahmann, Jannik, et al.
Publicado: (2023)

Painful and recurring injection site reaction to alirocumab and evolocumab in a young woman with familial hypercholesterolemia and effective therapeutic alternative based on inclisiran: a case report
por: Allevi, Massimiliano, et al.
Publicado: (2023)

Targeting ApoC3 Paradoxically Aggravates Atherosclerosis in Hamsters With Severe Refractory Hypercholesterolemia
por: Xu, Yitong, et al.
Publicado: (2022)

Impact of genetic testing on low-density lipoprotein cholesterol in patients with familial hypercholesterolemia (GenTLe-FH): a randomised waiting list controlled open-label study protocol
por: Nomura, Akihiro, et al.
Publicado: (2018)

Paradoxical reduction of plasma lipids and atherosclerosis in mice with adenine-induced chronic kidney disease and hypercholesterolemia
por: Padalkar, Mugdha V., et al.
Publicado: (2023)

SAT-566 Avoiding the Heartache: A Case of Familial Hypercholesterolemia
por: Kinaan, Mustafa, et al.
Publicado: (2020)

Women Specific Characteristics and 1-Year Outcome Among Patients Hospitalized for Peripheral Artery Disease: A Monocentric Cohort Analysis in a Tertiary Center
por: Détriché, Grégoire, et al.
Publicado: (2022)

SUN-070 Asymptomatic Patients with Homozygous Familial Hypercholesterolemia: A Challenge
por: Lam, Cesar, et al.
Publicado: (2019)

Risk factors for heart, cerebrovascular, and kidney diseases: evaluation of potential side effects of medications to control hypertension, hyperglycemia, and hypercholesterolemia
por: Nawata, Kazumitsu
Publicado: (2023)

Familial hypercholesterolemia revealed by multiple xanthomas
por: Elouarradi, Nassiba, et al.
Publicado: (2018)

Stroke distribution patterns and characteristics in Kenya’s leading public health tertiary institutions: Kenyatta National Hospital and Moi Teaching and Referral Hospital
por: Lydia, Kaduka, et al.
Publicado: (2018)

Autosomal Recessive Hypercholesterolemia Caused by a Novel LDLRAP1 Variant and Membranous Nephropathy in a Chinese Girl: A Case Report
por: Feng, Siqin, et al.
Publicado: (2022)

Genetically confirmed familial hypercholesterolemia in outpatients with hypercholesterolemia
por: Wang, Xu, et al.
Publicado: (2018)

Adeno-Associated Virus-Mediated Gain-of-Function mPCSK9 Expression in the Mouse Induces Hypercholesterolemia, Monocytosis, Neutrophilia, and a Hypercoagulative State
por: Louloudis, Georgios, et al.
Publicado: (2021)

Causal effect of gallstone disease on the risk of coronary heart disease or acute myocardial infarction: a Mendelian randomization study
por: Fu, Qingan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lutplrjjj4vojcmo883hpopc89